NASDAQ · Financial Statements

ADARx Pharmaceuticals, Inc. (ADRX) Revenue, Earnings & Financial Statements

$13.82 NASDAQ: ADRX Market Cap $1.53B

Data as of Nov 17, 2026 close · Statements through the quarter ended Sep 2026 · Source: Financial Modeling Prep (methodology)

ADARx Pharmaceuticals, Inc. most recently reported annual revenue of $3.0M, a net loss of $73.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Income Statement — 1 Years (USD millions)

Metric2025
Revenue$3.0M
Operating Expenses$92.0M
Operating Profit−$88.0M
Operating Margin-2562.1%
Other Income$15.0M
Interest$0
Depreciation$2.0M
Profit Before Tax−$73.0M
Tax rate (%)0.0%
Net Profit−$73.0M
EPS−$0.97

Quarterly Results — Last 4 Quarters (USD millions)

MetricDec '25Mar '26Jun '26Sep '26
Revenue$2.0M$2.0M$1.0M$2.0M
Operating Expenses$26.0M$29.0M$31.0M$34.0M
Operating Profit−$25.0M−$27.0M−$30.0M−$32.0M
Operating Margin-1522.8%-1264.3%-4006.8%-1451.4%
Interest$0$0$0$0
Profit Before Tax−$20.0M−$23.0M−$26.0M−$28.0M
Tax rate (%)0.0%0.0%0.0%0.0%
Net Profit−$20.0M−$23.0M−$26.0M−$28.0M
EPS−$1.73−$0.22−$0.24−$0.27

Balance Sheet — 1 Years (USD millions)

Metric2025
Total Assets$508.0M
Current Assets$493.0M
Cash$67.0M
Inventory$0
Receivables$0
Fixed Assets$12.0M
Capital Work in Progress$0
Investments$413.0M
Other Assets$0
Total Liabilities$710.0M
Current Liabilities$30.0M
Borrowings$8.0M
Other Liabilities$702.0M
Equity$0
Reserves−$202.0M

Cash Flow Statement — 1 Years (USD millions)

Metric2025
Operating Cash Flow$262.0M
Investing Cash Flow−$213.0M
Financing Cash Flow$0
Net Cash Flow$52.0M
Free Cash Flow$259.0M

ADARx Pharmaceuticals, Inc. (ADRX) financials — frequently asked questions

What is ADARx Pharmaceuticals, Inc.'s annual revenue?

ADARx Pharmaceuticals, Inc. (ADRX) reported annual revenue of $3.0M in its most recent fiscal year.

What is ADARx Pharmaceuticals, Inc.'s net profit?

ADARx Pharmaceuticals, Inc. (ADRX) reported a net loss of $73.0M in its most recent fiscal year.

Revenue and earnings of other Biotechnology stocks

VRTX revenue $12.1BREGN revenue $14.3BMRNA revenue $1.9BRVMD financialsROIV revenue $8.0MINSM revenue $606.0MUTHR revenue $3.2BINCY revenue $5.1BALNY revenue $3.7BASND revenue $692.0MAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
ADRX Overview ADRX Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.